Yeah the key for cellular therapies coupled with manufacturing and FDA approval (initial + ongoing re: approval mode) is the IP in the array matrix, which Si is clearly reiterating was effectively in place for MSB-GVHD0001, clarification of which has now been accepted by FDA. Should turn the real scientists back on in my ignore list at this critical juncture but...nah, easter Sunday's no time for religious zealots.
Yeah the key for cellular therapies coupled with manufacturing...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.110(11.1%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.11 | 95.5¢ | $15.75M | 15.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 79396 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 60351 | 4 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
0.110 ( 10.8 %) |
||||
| Open | High | Low | Volume | ||
| 96.5¢ | $1.11 | 95.5¢ | 2700730 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| MSB (ASX) Chart |